相關閱讀資料
突觸傳遞的生化學與藥理學
因舊版課程無指定課堂作業與考試,因此統整所有作業、講義、考試內容合併列出。
突觸傳遞的生化學與藥理學
因舊版課程無指定課堂作業與考試,因此統整所有作業、講義、考試內容合併列出。
Cooper, Bloom, and Roth. 《神經藥理學之生化基礎》第二章〈神經藥理學之細胞基礎〉. 第七版。紐約:牛津大學出版社,1996, 9-48.
Cooper, Bloom, and Roth. "Cellular Foundations of Neuropharmacology." Chap. 2 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 9-48.
------. 《神經藥理學之生化基礎》第一章〈導論〉. 第七版。紐約:牛津大學出版社,1996, 3-8.
------. "Introduction." Chap. 1 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 3-8.
------. 《神經藥理學之生化基礎》第三章〈神經藥理學之分子基礎.〉. 第七版。
------. "Molecular Foundations of Neuropharmacology." Chap. 3 in The Biochemical Basis of Neuropharmacology. 7th ed.
紐約:牛津大學出版社,1996, 75-81.
New York: Oxford University Press, 1996, 75-81.
《基礎神經生物學中的中樞神經系統的神經化學系統》.20-24.
Neurochemical Systems in the Central Nervous System in Basic Neurobiology. 20-24.
Tobin, A. 《基礎神經化學:分子、細胞、和醫學的觀點》G.J. Siegel 編輯. 紐約:烏鴉出版有限公司,1994, 493-513,〈哺乳類動物神經系統中的基因表現〉
Tobin, A. "Gene Expression in the Mammalian Nervous System." In Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Edited by G. J. Siegel. New York: Raven Press Ltd., 1994, 493-513.
酯質
Lipids
Agranoff, B. W., 和 A. K. Hajra. 《基礎神經化學中的酯質:分子、細胞、和醫學的觀點》G.J. Siegel 編輯. 紐約:烏鴉出版有限公司,1994, 97-116.
Agranoff, B. W., and A. K. Hajra. Lipids in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Edited by G. J. Siegel. New York: Raven Press Ltd., 1994, 97-116.
Betz, A. L. 《聯合公報》45. 第7號 (1986): 2050-2054.,〈穿越血腦障的離子運送.〉.
編者註:Proc. = Proceeding,活動或會議等紀錄及公報
Betz, A. L. "Transport of Ions Across the Blood-Brain Barrier." Federation Proc. 45, no. 7 (1986): 2050-2054.
Brownlees, J., 和 C. H. Williams. 《神經化學期刊》. 60, 第三號 (1993): 793-803,〈n, ?, 和哺乳類動物的血腦障〉.
Brownlees, J., and C. H. Williams. "Peptidases, Peptides, and the Mammalian Blood-Brain Barrier." J. Neurochem. 60, no. 3 (1993): 793-803.
Pardridge, W. M. 《營養和腦》第一冊. R. J. Wurtman 和 J. J. Wurtman編輯。紐約:烏鴉出版有限公司,1977, 142-175 ,〈胺基酸在腦內調節的出現機率〉.
Pardridge, W. M. "Regulation of Amino Acid Availability to the Brain." In Nutrition and the Brain. Vol. 1. Edited by R. J. Wurtman, and J. J. Wurtman. New York: Raven Press, 1977, 142-175.
Temburni, M. K., and M. H. Jacob. 《美國國家科學協會公報》98,第七號. (2001): 3631-3632.,〈神經膠質在腦內的新功能..〉
Temburni, M. K., and M. H. Jacob. "New Functions for Glia in the Brain." Proc. Natl. Acad. Sci. USA 98, no. 7 (2001): 3631-3632.
乙醯膽鹼
Acetylcholine
Blusztajn, J. K.,和 R.J. Wurtman. .《科學》221 (1983): 614-620,〈膽素和膽鹼激性的神經細胞.〉
Blusztajn, J. K., and R. J. Wurtman. "Choline and Cholinergic Neurons." Science 221 (1983): 614-620.
Cooper, Bloom, and Roth. 《神經藥理學之生化基礎》第七章〈乙醯膽鹼〉, 第七版。紐約:牛津大學出版社,1996, 194-225.
Cooper, Bloom, and Roth. "Acetylcholine." Chap. 7 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 194-225.
------. 《神經藥理學之生化基礎》第十三章〈神經和精神疾病的治療〉,第七版。紐約:牛津大學出版社,1996, 500-501.
------. "Treating Neurological and Psychiatric Diseases." Chap. 13 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 500-501.
Nitsch, R. M., J. K. Blusztajn, A. G. Pittas, B. E. Slack, J. H. Growdon, 和 R. J. Wurtman. 《美國國家科學協會腦科學公報》89 (1992): 1671-1675,〈阿爾滋海默症中細胞膜缺陷的證據.〉
Nitsch, R. M., J. K. Blusztajn, A. G. Pittas, B. E. Slack, J. H. Growdon, and R. J. Wurtman. "Evidence for a Membrane Defect in Alzheimer Disease." Brain Proc. Natl. Acad. Sci. USA 89 (1992): 1671-1675.
Ulus, I. H., R. J. Wurtman, C. Mauron, 和 J. K. Blusztajn. 《腦研究》484 (1989): 217-227,〈在老鼠紋狀體細胞膜中,膽素增加乙醯膽鹼的釋放和保護來自刺激所引發的磷酯濃度下降.〉
Ulus, I. H., R. J. Wurtman, C. Mauron, and J. K. Blusztajn. "Choline Increases Acetylcholine Release and Protects Against the Stimulation-Induced Decrease in Phosphatide Levels within Membranes of Rat Corpus Striatum." Brain Research 484 (1989): 217-227.
Ulus, I. H., M. C. Scally, 和 R. K. Wurtman,《藥理學期刊和實驗性治療》204, 第三號. (1978): 676-682,〈膽素加強由苯氧芐胺鹽酸鹽、羥基多巴胺 、胰島素或暴露於寒冷中所催發的腎酪氨酸羥化的催化反應.〉
Ulus, I. H., M. C. Scally, and R. J. Wurtman. "Enhancement by Choline of the Induction of Adrenal Tyrosine Hydroxylase by Phenoxybenzamine, 6-Hydroxydopamine, Insulin or Exposure to Cold." J. Pharmacol. Exp. Ther. 204, no. 3(1978): 676-682.
正腎上腺素和腎上腺素
Norephinephrine and Epinephrine
Cooper, Bloom, and Roth. 《神經藥理學之生化基礎》第八章〈正腎上腺素和腎上腺素〉,第七版。紐約:牛津大學出版社,1996, 226-292.
Cooper, Bloom, and Roth. "Norepinephrine and Epinephrine." Chap. 8 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 226-292.
------. 《神經藥理學之生化基礎》第十三章〈神經和精神疾病的治療〉, 第七版。紐約:牛津大學出版社,1996, 487-493.
------. "Treating Neurological and Psychiatric Diseases." Chap. 13 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 487-493.
Insel, P. A. 《新英格蘭醫學期刊》334, 第九號 (1996): 580-585,〈腎上腺素受器-進化的概念和臨床的意義〉
Insel, P. A. "Adrenergic Receptors-Evolving Concepts and Clinical Implications." N. Engl. J. Med. 334, no. 9 (1996): 580-585.
Wurtman R. J., 和 J. Axelrod. 《生物化學期刊》241, 第十號. (1965): 2301-2305,〈腎髓質中由腎皮質膽固醇所控制的腎上腺素之酵素合成〉
Wurtman R. J., and J. Axelrod. "Control of Enzymatic Synthesis of Adrenaline in the Adrenal Medulla by Adrenal Cortical Steroids." J. Biol. Chem. 241, no. 10 (1965): 2301-2305.
Wurtman, R. J., A. Casper, L. Pohorecky 和 F. C. Bartter. 《美國國家科學協會公報》61 (1968): 522-528,〈被切除垂體的狗表現由胰島素所誘發的腎上腺素分泌之減弱.〉
Wurtman, R. J., A. Casper, L. Pohorecky and F. C. Bartter. "Impaired Secretion of Epinephrine in Response to Insulin Among Hypophysectomized Dogs." Proc. N. A. S. 61 (1968): 522-528.
Wurtman, R. J. 《神經資訊處理系統》3, (1988): 158-163,〈由先驅物濃度所控制的突觸前部胺神經傳遞質之釋放〉
Wurtman, R. J. "Presynaptic Control of Release of Amine Neurotransmitters by Precursor Levels." NIPS 3 (1988): 158-163.
多巴胺
Dopamine
Acworth, I. N., M. J. During, 和 R. J. Wurtman. 《腦研究會報》21, 第三號. (1988): 473-477,〈酪胺酸:在兒茶酚胺釋放上的作用.〉
Acworth, I. N., M. J. During, and R. J. Wurtman. "Tyrosine: Effects on Catecholamine Release." Brain Res. Bull. 21, no. 3 (1988): 473-477.
Anden, N. E., M. Grabowska-Anden, 和 B. Liljenberg. 《神經傳遞期刊》57, (1983): 129-137,〈在不同腦部位裡多巴胺神經細胞上的動作受器之存在.〉
Anden, N. E., M. Grabowska-Anden, and B. Liljenberg. "On the Presence of Autoreceptors on Dopamine Neurons in Different Brain Regions." J. Neural Transmission 57 (1983): 129-137.
Bjorklund, A., 和 O. Lindvall. 《自然醫學》6, (2000): 1207-1208,〈帕金森氏症基因療法進入臨床.〉
Bjorklund, A., and O. Lindvall. "Parkinson Disease Gene Therapy Moves Toward the Clinic." Nature Medicine 6 (2000): 1207-1208.
Burns, R. S., P. A. LeWitt, M. H. Ebert, H. Pakkenberg, 和 I. J Kopin. 《新英格蘭醫學期刊》312, 第二十二號. (1985): 1418-1421,〈紋狀體多巴胺不足的臨床症狀.〉
Burns, R. S., P. A. LeWitt, M. H. Ebert, H. Pakkenberg, and I. J Kopin. "The Clinical Syndrome of Striatal Dopamine Deficiency." N. Engl. J. Med. 312, no. 22 (1985): 1418-1421.
Cooper, Bloom, and Roth. 《神經藥理學之生化基礎》第九章〈多巴胺〉 第七版。紐約:牛津大學出版社,1996, 293-351.
Cooper, Bloom, and Roth. " Dopamine." Chap. 9 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 293-351.
------. 《神經藥理學之生化基礎》第十三章〈神經和精神疾病的治療〉 第七版。紐約:牛津大學出版社,1996, 493-499, 501-506.
------. "Treating Neurological and Psychiatric Diseases." Chap. 13 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 493-499, 501-506.
Guillin, O., J. Diaz, P. Carroll, N. Griffon, J. C. Schwartz, 和 P. Sokoloff. 《自然》411, (2001): 86-89,〈腦源性神經營養因素控制多巴胺D3受器的表現和觸發行動的感受.〉
Guillin, O., J. Diaz, P. Carroll, N. Griffon, J. C. Schwartz, and P. Sokoloff. "BDNF Controls Dopamine D3 Receptor Expression and Triggers Behavioural Sensitization." Nature 411 (2001): 86-89.
Schultz, W., P. Dayan, 和 P. R. Montague. 《科學》275 (1997): 1593-1599,〈預測和回報反應的神經基質.〉
Schultz, W., P. Dayan, and P. R. Montague. "A Neural Substrate of Prediction and Reward." Science 275 (1997): 1593-1599.
Seeman, P. 《科學美國人:科學和醫學》2, 第五號. (1995): 28-37,〈多巴胺受器和精神病〉
Seeman, P. "Dopamine Receptors and Psychosis." Scientific American: Science & Medicine 2, no. 5 (1995): 28-37.
Strange, P. G. 《Tocris 評論》15 (2000). Bristol, 英國: Tocris Cookson 有限公司,〈多巴胺受器〉
Strange, P. G. "Dopamine Receptors." Tocris Reviews 15 (2000). Bristol, UK: Tocris Cookson Ltd.
White, F. J. 《自然》411 (2001): 35-37,〈推動多巴胺受器〉
White, F. J. "Dopamine Receptors Get a Boost." Nature 411 (2001): 35-37.
Williams G. V., 和 P. S. Goldman-Rakic. 《自然》376 (1995): 572-575,〈由額葉前部多巴胺D1受器所調節的記憶區.〉
Williams G. V., and P. S. Goldman-Rakic. "Modulation of Memory Fields by Dopamine D1 Receptors in Prefrontal Cortex." Nature 376 (1995): 572-575.
羥色胺
Serotonin
Cooper, Bloom, and Roth. 《神經藥理學之生化基礎》第十章〈羥色胺和組織胺〉 第七版。
Cooper, Bloom, and Roth. "Serotonin and Histamine." Chap. 10 in The Biochemical Basis of Neuropharmacology. 7th ed.
紐約:牛津大學出版社,1996, 352-391.
New York: Oxford University Press, 1996, 352-391.
------. 《神經藥理學之生化基礎》第十三章〈神經和精神疾病的治療〉 第七版。紐約:牛津大學出版社,1996, 487-493.
------. "Treating Neurological and Psychiatric Diseases." Chap. 13 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 487-493.
Fernstrom, J. D., 和 R. J. Wurtman. 《科學》174 (1971): 1023-1025,〈腦羥色胺的反應內容:在攝取碳水化合物後增加.〉
Fernstrom, J. D., and R. J. Wurtman. "Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet." Science 174 (1971): 1023-1025.
------. 《科學》173 (1971): 149-152,〈腦羥色胺的反應內容:生理上的依賴血漿中色氨酸的濃度.〉
------. "Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels." Science 173 (1971): 149-152.
------. 《科學》178 (1972): 414-416,〈腦羥色胺的反應內容:由血漿中的中性胺基酸做生理上的調整.〉
------. "Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids." Science 178 (1972): 414-416.
Martin, G. M. 《中樞神經藥物評論》3, 第三號 (1997): 294-299,〈羥色胺受器研究的進展:分子生物學、信號傳導和治療學〉
Martin, G. M. "Advances in Serotonin Receptor Research: Molecular Biology, Signal Transduction and Therapeutics." CNS Drug Reviews 3, no. 3 (1997): 294-299.
Nishizawa, S., C. Benkelfat, S. N. Young, M. Leyton, S. Mzengeza, C. de Montigny, P. Blier, 和 M. Diksic. 《美國國家科學協會公報》94 (1997): 5308-5313,〈男性和女性在人腦內羥色胺合成速率的不同.〉
Nishizawa, S., C. Benkelfat, S. N. Young, M. Leyton, S. Mzengeza, C. de Montigny, P. Blier, and M. Diksic. "Differences between Males and Females in Rates of Serotonin Synthesis in Human Brain." Proc. Natl. Acad. Sci. USA 94 (1997): 5308-5313.
O'Rourke, D., J. J. Wurtman, R. J. Wurtman, R. Chebli, 和R. Gleason. 《臨床精神病學期刊》50, 第九號 (1989): 343-347,〈用食慾抑制劑治療季節性憂鬱症.〉
O'Rourke, D., J. J. Wurtman, R. J. Wurtman, R. Chebli, and R. Gleason. "Treatment of Seasonal Depression With d-Fenfluramine." J. Clin. Psychiatry 50, no. 9 (1989): 343-347.
Schaechter, J. D., 和R. J. Wurtman. 《神經化學期刊》53, 第六號. (1989): 1925-1933,〈色氨酸的可獲性調節老鼠下丘體切片的羥色胺之釋放.〉
Schaechter, J. D., and R. J. Wurtman. "Tryptophan Availability Modulates Serotonin Release from Rat Hypothalamic Slices." J. Neurochem. 53, no. 6 (1989): 1925-1933.
Wurtman, R. J., 和J. J. Wurtman. 《科學美國人》1, (1989): 68-75,〈碳水化合物和憂鬱症.〉
Wurtman, R. J., and J. J. Wurtman. "Carbohydrates and Depression." Scientific American 1 (1989): 68-75.
Wurtman, J. J., 和R. J. Wurtman. 《國際肥胖症期刊》8, 第一號. (1984): 79-84,〈食慾抑制劑選擇性的減少肥胖實驗對象對碳水化合物之吸收而不是蛋白質.〉
Wurtman, J. J., and R. J. Wurtman. "D-Fenfluramine Selectively Decreases Carbohydrate But Not Protein Intake in Obese Subjects." Intl. J. Obesity 8, no. 1 (1984): 79-84.
黑色素和睡眠
Melatonin and Sleep
Lynch, H. J., R. J. Wurtman, M. A. Moskowitz, M. C. Archer, 和M. H. Ho. 《科學》187, (1975): 169-171,〈人類泌尿系統中的黑色素週期.〉
Lynch, H. J., R. J. Wurtman, M. A. Moskowitz, M. C. Archer, and M. H. Ho. "Daily Rhythm in the Human Urinary Melatonin." Science 187 (1975), 169-171.
Wurtman, R. J., J. Axelrod, 和E. W. Chu. 《科學》141, (1963): 277-278,〈黑色素,松果體物質:對老鼠卵巢的作用〉
Wurtman, R. J., J. Axelrod, and E. W. Chu. "Melatonin, a Pineal Substance: Effect on the Rat Ovary." Science 141 (1963): 277-278.
Zhdanova, I. V., R. J. Wurtman, M. M. Regan, J. A. Taylor, J. P. Shi, 和O. U. Leclair. 《臨床內分泌新陳代謝期刊》86, 第十號 (2001): 4727-4730,〈對老年性不眠症的黑色素療法.〉
Zhdanova, I. V., R. J. Wurtman, M. M. Regan, J. A. Taylor, J. P. Shi, and O. U. Leclair. "Melatonin Treatment for Age-Related Insomnia." J. Clin. Endocrin. Metab. 86, no. 10 (2001): 4727-4730.
Zhdanova, I. V., et al. 《臨床藥理學治療法》57, (1995): 552-558,〈晚間攝取低劑量黑色素的睡眠引起之影響.〉
Zhdanova, I. V., et al. "Sleep-Inducing Effects of Low Doses of Melatonin Ingested in the Evening." Clin. Pharmacol. Ther. 57 (1995): 552-558.
麩胺酸酯和天冬胺酸酯
Glutamate and Aspartate
Cooper, Bloom, 和Roth. 《神經藥理學之生化基礎》第六章〈胺基酸神經傳遞質〉 第七版。
Cooper, Bloom, and Roth. "Amino Acid Transmitters." Chap. 6 in The Biochemical Basis of Neuropharmacology. 7th ed.
紐約:牛津大學出版社,1996, 171-193.
New York: Oxford University Press, 1996, 171-193.
Krystal, J. H., et al. 《哈佛評論精神病學》7, (1999): 125-143,〈用於腦病變症候群中的氨酸鹽能官能障礙和藥物療法的探測劑,─N-甲基-D-天冬胺酸酯促效劑和拮抗劑.〉
Krystal, J. H., et al. "NMDA Agonists and Antagonists as Probes of Glutamatergic Dysfunction and Pharmacotherapies in Neuropsychiatric Disorders." Harvard Rev. Psychiatry 7 (1999): 125-143.
Malenka, R. C., 和R.A. Nicoll. 《科學》285, (1999): 1870-1874,〈長效活化─十年的進展?〉
Malenka, R. C., and R.A. Nicoll. "Long-Term Potentiation-A Decade of Progress?" Science 285 (1999): 1870-1874.
Schoepp, D. D., J. A. Monn, G. J. Marek, G. Aghajanian, 和B. Moghaddam. 《中樞神經系統藥物評論》5, 第一號. (1999): 1-12,〈LY354740:有系統的活化mGlu2/mGlu3受器之促效劑〉
(*mGlu2和mGlu3為兩種麩胺酸酯(glutamate)的受器,當活化後由G-蛋白質(G-protein)在細胞膜裡側開始傳遞訊息到第二信使系統(second messenger system)進而觸發一連串的反應(cascade effect))
Schoepp, D. D., J. A. Monn, G. J. Marek, G. Aghajanian, and B. Moghaddam. "LY354740: A Systematically Active mGlu2/mGlu3 Receptor Agonist." CNS Drug Reviews 5, no. 1 (1999): 1-12.
Schoepp, D. D. 《國際神經化學》24, 第五號. (1994): 439-449,〈新陳代謝性麩胺酸酯受器的亞型之新功能.〉
Schoepp, D. D. "Novel Functions for Subtypes of Metabotropic Glutamate Receptors." Neurochem. Int.24, no. 5 (1994): 439-449.
伽馬安基丁酸和甘胺酸
GABA and Glycine
Anagnostaras, S. G., M. G. Craske, 和M. S. Fanselow. 《自然神經科學》2, 第九號. (1999): 780-782,〈焦慮症:在基因和經驗的交叉口.〉
Anagnostaras, S. G., M. G. Craske, and M. S. Fanselow. "Anxiety: At the Intersection of Genes and Experience." Nature Neurosci. 2, no. 9 (1999): 780-782.
Betz, H., 和C. M. Becker. 《國際蛋白質神經化學》13, 第二號. (1988): 137-146,〈哺乳類動物的甘胺酸受器:神經氯化物通道的生物學和構造〉
Betz, H., and C. M. Becker. "The Mammalian Glycine Receptor: Biology and Structure of a Neuronal Chloride Channel." Protein. Neurochem. Int. 13, no. 2 (1988): 137-146.
Cooper, Bloom, 和Roth. 《神經藥理學之生化基礎》第六章〈胺基酸神經傳遞質〉 第七版。
Cooper, Bloom, and Roth. "Amino Acid Transmitters." Chap. 6 in The Biochemical Basis of Neuropharmacology. 7th ed.
紐約:牛津大學出版社,1996, 126-171.
New York: Oxford University Press, 1996, 126-171.
Crestani, F., et al. 《自然神經科學》2, 第九號. (1999): 833-839,〈減少伽馬安基丁酸-A受器的叢集造成焦慮症的惡化和威脅性線索的偏見.〉
Crestani, F., et al. "Decreased GABA-A Receptor Clustering results in Enhanced Anxiety and a Bias for Threat Cues." Nature Neurosci. 2, no. 9 (1999): 833-839.
During, M. J., M. K. Ryder, 和D. D. Spencer. 《自然》376, (1995): 174-177,〈在顳葉癲癇的海馬體伽馬安基丁酸傳導值之功能.〉
During, M. J., M. K. Ryder, and D. D. Spencer. "Hippocampal GABA transporter function in temporal-lobe epilepsy." Nature 376 (1995): 174-177.
Gale, K., 和M. J. Iadarola. 《科學》208, (1980): 288-291,〈癲癇的保護和增加神經末梢伽馬安基丁酸:伽馬安基丁酸傳導抑制的延遲效應.〉
Gale, K., and M. J. Iadarola. "Seizure Protection and Increased Nerve-Terminal GABA: Delayed Effects of GABA Transmission Inhibition." Science 208 (1980): 288-291.
Martin, D. L., 和K. Rimvall. 《神經化學期刊》60, 第二號. (1993): 395-407,〈伽馬安基丁酸在腦中合成的控制.〉
Martin, D. L., and K. Rimvall. "Regulation of GABA Synthesis in the Brain." J. Neurochem. 60, no. 2 (1993): 395-407.
腺嘌呤和咖啡;組織胺和癢
Adenosine and Coffee; Histamine and Itch
Braas, K. M., A. C. Newby, V. S. Wilson, 和S. H. Snyder. 《神經科學期刊》6, 第七號. (1986): 1952-1961,〈由免疫細胞化學定位的含有腺嘌呤之腦內神經細胞.〉
Braas, K. M., A. C. Newby, V. S. Wilson, and S. H. Snyder. "Adenosine-Containing Neurons in the Brain Localized by Immunocytochemistry." J. Neurosci. 6, no. 7 (1986), 1952-1961.
Brown, S. J., S. James, M. Reddington, 和P. J. Richardson. 《神經化學期刊》55, 第一號. (1990): 31-38,〈A1和A2a嘌呤受器都可以調整紋狀體乙醯膽鹼的釋放.〉
Brown, S. J., S. James, M. Reddington, and P. J. Richardson. "Both A1 and A2a Purine Receptors Regulate Striatal Acetylcholine Release." J. Neurochem. 55, no. 1 (1990), 31-38.
Clarke, B., E. Rowland, P. J. Barnes, J. Till, D. E. Ward, 和E. A. Shinebourne. 《柳葉刀》 (1987): 299-301,〈用腺嘌呤立即和安全的終止兒童上心室性頻脈〉
Clarke, B., E. Rowland, P. J. Barnes, J. Till, D. E. Ward, and E. A. Shinebourne. "Rapid and Safe Termination of Supraventricular Tachycardia in Children by Adenosine." The Lancet (1987): 299-301.
Cooper, Bloom, 和Roth. 《神經藥理學之生化基礎》第十章〈羥色胺和組織胺〉, 第七版。
Cooper, Bloom, and Roth. "Serotonin and Histamine." Chap. 10 in The Biochemical Basis of Neuropharmacology. 7th ed.
紐約:牛津大學出版社,1996, 391-409.
New York: Oxford University Press, 1996, 391-409.
Fredholm, B. B. 《神經資訊處理系統》10, (1995): 122-128,〈中樞神經系統的腺嘌呤受器〉
Fredholm, B. B. "Adenosine Receptors in the Central Nervous System." NIPS 10 (1995): 122-128.
Shankley, N. P., G. F. Watt, 和J. W. Black. 《歐洲臨床研究期刊》25, 第一號. (1995): 12-18,〈組織胺H2受器的定義和位置.〉
Shankley, N. P., G. F. Watt, and J. W. Black. "Definition and Localization of Histamine H2 Receptors." Euro. J. Clin. Investig. 25, no. 1 (1995): 12-18.
Simons, F. E. R., 和K. J. Simons. 《藥物治療》330, 第二十三號. (1994): 1663-1670,〈藥理學和H1受器拮抗劑藥物的使用.〉
Simons, F. E. R., and K. J. Simons. "The Pharmacology and Use of H1-Receptor-Antagonist Drugs." Drug Therapy 330, no. 23 (1994): 1663-1670.
受器
Receptors
Anggard, E. 《柳葉刀》343, (1994): 1199-1206,〈氧化氮:介質,兇手和藥物.〉
Anggard, E. "Nitric Oxide: Mediator, Murderer, and Medicine." The Lancet 343 (1994): 1199-1206.
Cary, S. P. L., 和M. A. Marletta. 《臨床研究期刊》107, 第九號. (2001): 1071-1073,〈一氧化碳信號案:尚未定論.〉
Cary, S. P. L., and M. A. Marletta. "The Case of CO Signaling: Why is the Jury Still Out." J. Clin. Investig.107, no. 9 (2001): 1071-1073.
Cooper, Bloom, 和 Roth. 《神經藥理學之生化基礎》第十二章〈在學習和記憶中的細胞機制〉, 第七版。紐約:牛津大學出版社,1996, 459-479.
Cooper, Bloom, and Roth. "Cellular Mechanisms in Learning and Memory." Chap. 12 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 459-479.
------. 《神經藥理學之生化基礎》第五章〈神經結傳導的調節〉, 第七版。紐約:牛津大學出版社,1996, 103-125.
------. "Modulation of Synaptic Transmission." Chap. 5 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 103-125.
------. 《神經藥理學之生化基礎》第四章〈受器〉 第七版。紐約:牛津大學出版社,1996, 82-102.
------. "Receptors." Chap. 4 in The Biochemical Basis of Neuropharmacology. 7th ed. New York: Oxford University Press, 1996, 82-102.
Fitzpatrick, F. A., 和 R. Soberman. 《臨床研究期刊》107, 第十一號. (2001): 1347-1351,〈十二酸的被控制形成.〉
Fitzpatrick, F. A., and R. Soberman. "Regulated Formation of Eicosanoids." J. Clin. Investig. 107, no. 11 (2001): 1347-1351.
Sudhof, T. C. 《神經細胞》28, 第二號. (2000): 317-320,〈再次探討神經結小泡週期.〉
Sudhof, T. C. "The Synaptic Vesicle Cycle Revisited." Neuron 28, no. 2 (2000): 317-320.
Mongada, S., 和A. Higgs. 《新英格蘭醫學期刊》329, 第二十七號. (1993): 2002-2012,〈左旋精氨酸-氧化氮途徑.〉
Mongada, S., and A. Higgs. "The L-Arginine-Nitric Oxide Pathway." N. Engl. J. Med. 329, no. 27 (1993): 2002-2012.
精神病的類別
Categories of Psychiatric Disease
Cattaneo, E., D. Rigamonti, D. Goffredo, C. Zuccato, F. Squitieri, 和S. Sipione. 《神經科學的潮流》24, 第三號. (2001): 182-188,〈失去正常效用的亨丁頓蛋白:亨丁頓舞蹈症研究的新發展.〉
Cattaneo, E., D. Rigamonti, D. Goffredo, C. Zuccato, F. Squitieri, and S. Sipione. "Loss of Normal Huntingtin Function: New Developments in Huntington's Disease Research." Trends Neurosci. 24, no. 3 (2001): 182-188.
Cowan, W. M., 和E. R. Kandel. 《美國醫學協會期刊》285, 第五號. (2001): 594-600,〈神經學和精神病學的前景.〉
Cowan, W. M., and E. R. Kandel. "Prospects for Neurology and Psychiatry." JAMA 285, no. 5 (2001): 594-600.
Fava M., 和K. S. Kendler. 《神經細胞》28, 第二號. (2000): 335-41,〈主要的憂鬱症.〉
Fava M., and K. S. Kendler. "Major Depressive Disorder." Neuron 28, no. 2 (2000): 335-41.
Hyman, S. 《神經細胞》28 (2000): 321-323,〈精神疾病:由基因所引起的神經迴路和神經通訊障礙.〉
Hyman, S. "Mental Illness: Genetically Complex Disorders of Neural Circuitry and Neural Communication." Neuron 28 (2000): 321-323.
Leckman, J. F., 和M. A. Riddle. 《神經細胞》28 (2000): 349-354,〈妥瑞氏症狀:當習慣形成系統形成它們自己的習慣?〉
Leckman, J. F., and M. A. Riddle. "Tourette's Syndrome: When Habit-Forming Systems Form Habits of Their Own?" Neuron 28 (2000): 349-354.
?神經傳遞質
Peptide Neurotransmitters
Cooper, Bloom, 和Roth. 《神經藥理學之生化基礎》第十一章〈神經活化之細胞傳遞質〉 第七版。
Cooper, Bloom, and Roth. "Neuroactive Peptides." Chap. 11 in The Biochemical Basis of Neuropharmacology. 7th ed.
紐約:牛津大學出版社,1996, 410-458.
New York: Oxford University Press, 1996, 410-458.
Hokfelt, T., J. F. Rehfeld, L. Skirboll, B. Ivemark, M. Goldstein, 和 K. Markey. 《自然》285, (1980): 476-477,〈多巴胺和膽囊收縮素同時存在於中央邊緣葉神經細胞的證據.〉
Hokfelt, T., J. F. Rehfeld, L. Skirboll, B. Ivemark, M. Goldstein, and K. Markey. "Evidence for Coexistence of Dopamine and CCK in Meso-Limbic Neurones." Nature 285 (1980): 476-477.
Nichols, M. L., et al. 《科學》268 (1999): 1558-1561,〈由脊椎神經細胞表現的P物質受器傳導的慢性疼痛.〉
Nichols, M. L., et al. "Transmission of Chronic Nociception by Spinal Neurons Expressing the Substance P Receptor." Science 268 (1999): 1558-1561.